Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study

Hareth Nahi*, Saad Z. Usmani, Maria Victoria Mateos, Niels W.C.J. van de Donk, Albert Oriol, Torben Plesner, Nibedita Bandyopadhyay, Peter Hellemans, Brenda Tromp, Ivo Nnane, Donna Zemlickis, Ajai Chari, Philippe Moreau

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

16 Downloads (Pure)
Original languageEnglish
JournalLeukemia and Lymphoma
Issue number2
Pages (from-to)468-472
Publication statusPublished - 2023

Cite this